|
Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, November 22, 2016 ) " Chronic Asthma-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the Chronic Asthma. The DelveInsight'sReport covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA designations details. DelveInsight's Report also provides detailed information on the discontinued and dormant drugs that have gone inactive over the years for Chronic Asthma. DelveInsight's Report also assesses the Chronic Asthma therapeutics by Monotherapy, Combination products, Molecule type and Route of Administration.
For more information http://www.reportsweb.com/chronic-asthma-pipeline-insights-2016
Table of Contents
- Chronic Asthma Overview
- Chronic Asthma Pipeline Therapeutics
- Chronic Asthma Therapeutics under Development by Companies
- Chronic Asthma Filed and Phase III Products
- Comparative Analysis
- Chronic Asthma Phase II Products
- Comparative Analysis
- Chronic Asthma Phase I and IND Filed Products
- Comparative Analysis
- Chronic Asthma Discovery and Pre-Clinical Stage Products
- Comparative Analysis
- Drug Candidate Profiles
- Chronic Asthma - Therapeutics Assessment
- Assessment by Monotherapy Products
- Assessment by Combination Products
- Assessment by Route of Administration
- Assessment by Molecule Type
- Chronic Asthma - Discontinued Products
- Chronic Asthma - Dormant Products
- Companies Involved in Therapeutics Development for Chronic Asthma
- Appendix
- Methodology
- Contact Us
- Disclaimer
Request Sample Copy http://www.reportsweb.com/inquiry&RW000183038/sample
ReportsWeb.com
Priya Sisodia
+1-646-491-9876
sales@reportsweb.com
Source: EmailWire.Com 
Source: EmailWire.com
|
|
|
|
